Remove tag commercial
article thumbnail

3 Things Generative AI Can Do for Commercial Pharma Right Now

PM360

In commercial, issues related to Medical, Legal, and Regulatory (MLR) review compliance will need to be carefully managed as well. And while it is still too early to predict exactly how generative AI/LLMs will specifically impact pharmaceutical commercialization, several promising use cases are already emerging.

Pharma 97
article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. DTC commercials will be replaced by unbranded ads that look to engage patients and caregivers by forming a relationship based on making them more intelligent about their treatments.

Pharma 210
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pioneering the Path Pre- and Post-Launch Strategies

PM360

Clinical-Medical-Commercial Collaboration Within the intricate web that is the healthcare ecosystem, stakeholders perceive pharmaceutical companies as singular entities, irrespective of internal divisions between Medical Affairs, clinical and commercial teams.

Medical 52
article thumbnail

EVERSANA and Amazon Web Services Introduce Transformative Medical & Regulatory Review AI Solution

PM360

Using Amazon Bedrock and Amazon Textract, disparate datasets are aggregated and tagged, reducing time and effort throughout the process while providing an accurate and expedited user experience.

Medical 52
article thumbnail

Novel nanofiltration method for microbial biosurfactant downstream processing

European Pharmaceutical Review

Methods of the microbial biosurfactant study The first stage of the downstream method combined TAG selective removal from glycolipids. In the study three commercially available membranes (GMT-oNF-2, PuraMEm-600 and DuramMem-500) and several homemade membranes were casted from 22, 24 or 26 percent (w/v) polybenzimidazole (PBI) solutions.

article thumbnail

Free access to Zolgensma curbed, says Novartis

pharmaphorum

Zolgensma meanwhile is now approved in 45 countries, with over 2,500 patients treated globally across clinical trials, managed access programs, and in the commercial setting. ” Zolgensma is one of the most expensive therapies available, with a price tag of around $2.1

article thumbnail

How to Optimize Content for SEO to Rank Higher

Healthcare Success

This process can apply to everything from building a better, clean site architecture to updating web pages with optimized title tags, meta description tags, headings, and body content that reflects what people are searching for. As with all aspects of SEO, content shouldn’t be “optimized” just for the search engine algorithms.